Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

NCT06674330 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies
Critical Illness

Interventions

OTHER: concentration of teicoplanin

Sponsor

National Taiwan University Hospital